Onychomycosis Treatment Market Size By Test (Distal Subungual Onychomycosis (DSO), White Superficial Onychomycosis (WSO), Proximal Subungual Onychomycosis (PSO), Candida Onychomycosis), By Treatment Type (Drug Treatment, Topical Therapy), By Drug Class (Allylamine, Azole, Griseofulvin), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online pharmacies), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Report Content

Chapter 1   Methodology

1.1    Methodology

1.2    Market definitions

1.3    Forecast parameters

1.4    Data sources

1.4.1    Secondary

1.4.1.1    Paid sources

1.4.1.2    Unpaid sources

1.4.2    Primary

Chapter 2   Executive Summary

2.1    Onychomycosis treatment industry 360° synopsis, 2016 – 2027

2.1.1    Business trends

2.1.2    Type trends

2.1.3    Treatment type trends

2.1.4    Drug class trends

2.1.5    Distribution channel trends

2.1.6    Regional trends

Chapter 3   Onychomycosis Treatment Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016 - 2027

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Increasing prevalence of diabetes worldwide

3.3.1.2    Growing awareness about the potential threats of onychomycosis

3.3.1.3    Rising prevalence of onychomycosis in adults and elderly population

3.3.2    Industry pitfalls and challenges

3.3.2.1    Side effects associated with onychomycosis treatment drugs

3.4    Growth potential analysis

3.4.1    By type

3.4.2    By treatment type

3.4.3    By drug class

3.4.4    By distribution channel

3.5    COVID-19 impact analysis

3.6    Porter’s analysis

3.7    Competitive landscape, 2020

3.7.1    Competitive matrix analysis, 2020

3.8    PESTEL analysis

Chapter 4   Onychomycosis Treatment Market, By Type

4.1    Key segment trends

4.2    Distal Subungual Onychomycosis (DSO)

4.2.1    Market size, by region, 2016 – 2027

4.3    White Superficial Onychomycosis (WSO)

4.3.1    Market size, by region, 2016 – 2027

4.4    Proximal Subungual Onychomycosis (PSO)

4.4.1    Market size, by region, 2016 – 2027

4.5    Candida Onychomycosis

4.5.1    Market size, by region, 2016 – 2027

4.6    Others

4.6.1    Market size, by region, 2016 – 2027

Chapter 5   Onychomycosis Treatment Market, By Treatment Type

5.1    Key segment trends

5.2    Drug treatment

5.2.1    Market size, by region, 2016 – 2027

5.3    Topical therapy

5.3.1    Market size, by region, 2016 – 2027

Chapter 6   Onychomycosis Treatment Market, By Drug Class

6.1    Key segment trends

6.2    Allylamine

6.2.1    Market size, by region, 2016 – 2027

6.3    Azole

6.3.1    Market size, by region, 2016 – 2027

6.4    Griseofulvin

6.4.1    Market size, by region, 2016 – 2027

6.5    Others

6.5.1    Market size, by region, 2016 – 2027

Chapter 7   Onychomycosis Treatment Market, By Distribution Channel

7.1    Key segment trends

7.2    Hospital Pharmacies

7.2.1    Market size, by region, 2016 – 2027

7.3    Retail Pharmacies

7.3.1    Market size, by region, 2016 – 2027

7.4    Online pharmacies

7.4.1    Market size, by region, 2016 – 2027

Chapter 8   Onychomycosis Treatment Market, By Region

8.1    Key regional trends

8.2    North America

8.2.1    Market size, by country 2016 – 2027

8.2.2    Market size, by type, 2016 – 2027

8.2.3    Market size, by treatment type, 2016 – 2027

8.2.4    Market size, by drug class, 2016 – 2027

8.2.5    Market size, by distribution channel, 2016 – 2027

8.2.6    U.S.

8.2.6.1    Market size, by type, 2016 – 2027

8.2.6.2    Market size, by treatment type, 2016 – 2027

8.2.6.3    Market size, by drug class, 2016 – 2027

8.2.6.4    Market size, by distribution channel, 2016 – 2027

8.2.7    Canada

8.2.7.1    Market size, by type, 2016 – 2027

8.2.7.2    Market size, by treatment type, 2016 – 2027

8.2.7.3    Market size, by drug class, 2016 – 2027

8.2.7.4    Market size, by distribution channel, 2016 – 2027

8.3    Europe

8.3.1    Market size, by country 2016 – 2027

8.3.2    Market size, by type, 2016 – 2027

8.3.3    Market size, by treatment type, 2016 – 2027

8.3.4    Market size, by drug class, 2016 – 2027

8.3.5    Market size, by distribution channel, 2016 – 2027

8.3.6    Germany

8.3.6.1    Market size, by type, 2016 – 2027

8.3.6.2    Market size, by treatment type, 2016 – 2027

8.3.6.3    Market size, by drug class, 2016 – 2027

8.3.6.4    Market size, by distribution channel, 2016 – 2027

8.3.7    France

8.3.7.1    Market size, by type, 2016 – 2027

8.3.7.2    Market size, by treatment type, 2016 – 2027

8.3.7.3    Market size, by drug class, 2016 – 2027

8.3.7.4    Market size, by distribution channel, 2016 – 2027

8.3.8    UK

8.3.8.1    Market size, by type, 2016 – 2027

8.3.8.2    Market size, by treatment type, 2016 – 2027

8.3.8.3    Market size, by drug class, 2016 – 2027

8.3.8.4    Market size, by distribution channel, 2016 – 2027

8.3.9    Italy

8.3.9.1    Market size, by type, 2016 – 2027

8.3.9.2    Market size, by treatment type, 2016 – 2027

8.3.9.3    Market size, by drug class, 2016 – 2027

8.3.9.4    Market size, by distribution channel, 2016 – 2027

8.3.10    Spain

8.3.10.1    Market size, by type, 2016 – 2027

8.3.10.2    Market size, by treatment type, 2016 – 2027

8.3.10.3    Market size, by drug class, 2016 – 2027

8.3.10.4    Market size, by distribution channel, 2016 – 2027

8.4    Asia Pacific

8.4.1    Market size, by country 2016 – 2027

8.4.2    Market size, by type, 2016 – 2027

8.4.3    Market size, by treatment type, 2016 – 2027

8.4.4    Market size, by drug class, 2016 – 2027

8.4.5    Market size, by distribution channel, 2016 – 2027

8.4.6    China

8.4.6.1    Market size, by type, 2016 – 2027

8.4.6.2    Market size, by treatment type, 2016 – 2027

8.4.6.3    Market size, by drug class, 2016 – 2027

8.4.6.4    Market size, by distribution channel, 2016 – 2027

8.4.7    Japan

8.4.7.1    Market size, by type, 2016 – 2027

8.4.7.2    Market size, by treatment type, 2016 – 2027

8.4.7.3    Market size, by drug class, 2016 – 2027

8.4.7.4    Market size, by distribution channel, 2016 – 2027

8.4.8    India

8.4.8.1    Market size, by type, 2016 – 2027

8.4.8.2    Market size, by treatment type, 2016 – 2027

8.4.8.3    Market size, by drug class, 2016 – 2027

8.4.8.4    Market size, by distribution channel, 2016 – 2027

8.4.9    South Korea

8.4.9.1    Market size, by type, 2016 – 2027

8.4.9.2    Market size, by treatment type, 2016 – 2027

8.4.9.3    Market size, by drug class, 2016 – 2027

8.4.9.4    Market size, by distribution channel, 2016 – 2027

8.4.10    Australia

8.4.10.1    Market size, by type, 2016 – 2027

8.4.10.2    Market size, by treatment type, 2016 – 2027

8.4.10.3    Market size, by drug class, 2016 – 2027

8.4.10.4    Market size, by distribution channel, 2016 – 2027

8.5    Latin America

8.5.1    Market size, by country 2016 – 2027

8.5.2    Market size, by type, 2016 – 2027

8.5.3    Market size, by treatment type, 2016 – 2027

8.5.4    Market size, by drug class, 2016 – 2027

8.5.5    Market size, by distribution channel, 2016 – 2027

8.5.6    Brazil

8.5.6.1    Market size, by type, 2016 – 2027

8.5.6.2    Market size, by treatment type, 2016 – 2027

8.5.6.3    Market size, by drug class, 2016 – 2027

8.5.6.4    Market size, by distribution channel, 2016 – 2027

8.5.7    Mexico

8.5.7.1    Market size, by type, 2016 – 2027

8.5.7.2    Market size, by treatment type, 2016 – 2027

8.5.7.3    Market size, by drug class, 2016 – 2027

8.5.7.4    Market size, by distribution channel, 2016 – 2027

8.5.8    Argentina

8.5.8.1    Market size, by type, 2016 – 2027

8.5.8.2    Market size, by treatment type, 2016 – 2027

8.5.8.3    Market size, by drug class, 2016 – 2027

8.5.8.4    Market size, by distribution channel, 2016 – 2027

8.6    Middle East and Africa

8.6.1    Market size, by country 2016 – 2027

8.6.2    Market size, by type, 2016 – 2027

8.6.3    Market size, by treatment type, 2016 – 2027

8.6.4    Market size, by drug class, 2016 – 2027

8.6.5    Market size, by distribution channel, 2016 – 2027

8.6.6    Saudi Arabia

8.6.6.1    Market size, by type, 2016 – 2027

8.6.6.2    Market size, by treatment type, 2016 – 2027

8.6.6.3    Market size, by drug class, 2016 – 2027

8.6.6.4    Market size, by distribution channel, 2016 – 2027

8.6.7    UAE

8.6.7.1    Market size, by type, 2016 – 2027

8.6.7.2    Market size, by treatment type, 2016 – 2027

8.6.7.3    Market size, by drug class, 2016 – 2027

8.6.7.4    Market size, by distribution channel, 2016 – 2027

8.6.8    South Africa

8.6.8.1    Market size, by type, 2016 – 2027

8.6.8.2    Market size, by treatment type, 2016 – 2027

8.6.8.3    Market size, by drug class, 2016 – 2027

8.6.8.4    Market size, by distribution channel, 2016 – 2027

Chapter 9   Company Profiles

9.1    Strategy dashboard, 2020

9.2    Novartis AG

9.2.1    Business overview

9.2.2    Financial data

9.2.3    Product landscape

9.2.4    Strategic outlook

9.2.5    SWOT analysis

9.3    Pfizer Inc.

9.3.1    Business overview

9.3.2    Financial data

9.3.3    Product landscape

9.3.4    Strategic outlook

9.3.5    SWOT analysis

9.4    Galderma Laboratories

9.4.1    Business overview

9.4.2    Financial data

9.4.3    Product landscape

9.4.4    Strategic outlook

9.4.5    SWOT analysis

9.5    Bausch Health Sciences

9.5.1    Business overview

9.5.2    Financial data

9.5.3    Product landscape

9.5.4    Strategic outlook

9.5.5    SWOT analysis

9.6    Moberg Pharma AB

9.6.1    Business overview

9.6.2    Financial data

9.6.3    Product landscape

9.6.4    Strategic outlook

9.6.5    SWOT analysis

9.7    Dr. Reddy’s Laboratories Ltd

9.7.1    Business overview

9.7.2    Financial data

9.7.3    Product landscape

9.7.4    Strategic outlook

9.7.5    SWOT analysis

9.8    Medimetriks Pharmaceuticals Inc.

9.8.1    Business overview

9.8.2    Financial data

9.8.3    Product landscape

9.8.4    Strategic outlook

9.8.5    SWOT analysis

9.9    Merz Pharma

9.9.1    Business overview

9.9.2    Financial data

9.9.3    Product landscape

9.9.4    Strategic outlook

9.9.5    SWOT analysis

9.10    Kaken Pharmaceutical Co. Ltd

9.10.1    Business overview

9.10.2    Financial data

9.10.3    Product landscape

9.10.4    Strategic outlook

9.10.5    SWOT analysis

9.11    Johnson & Johnson Services Inc.

9.11.1    Business overview

9.11.2    Financial data

9.11.3    Product landscape

9.11.4    Strategic outlook

9.11.5    SWOT analysis

9.12    GlaxoSmithKline plc

9.12.1    Business overview

9.12.2    Financial data

9.12.3    Product landscape

9.12.4    Strategic outlook

9.12.5    SWOT analysis

9.13    Taro Pharmaceuticals Industries Ltd

9.13.1    Business overview

9.13.2    Financial data

9.13.3    Product landscape

9.13.4    Strategic outlook

9.13.5    SWOT analysis
 

Data Tables

TABLE 1    Onychomycosis treatment industry 360° synopsis, 2016 – 2027

TABLE 2    Onychomycosis treatment market, 2016-2027 (USD Million)

TABLE 3    Onychomycosis treatment market, by type, 2016-2027 (USD Million)

TABLE 4    Onychomycosis treatment market, by treatment type, 2016-2027 (USD Million)

TABLE 5    Onychomycosis treatment market, by drug class, 2016-2027 (USD Million)

TABLE 6    Onychomycosis treatment market, by distribution channel, 2016-2027 (USD Million)

TABLE 7    Onychomycosis treatment market, by region, 2016-2027 (USD Million)

TABLE 8    Industry impact forces

TABLE 9    Distal subungual onychomycosis (DSO) market size, by region, 2016-2027 (USD Million)

TABLE 10    White superficial onychomycosis (WSO) market size, by region, 2016-2027 (USD Million)

TABLE 11    Proximal subungual onychomycosis (PSO) market size, by region, 2016-2027 (USD Million)

TABLE 12    Candida onychomycosis market size, by region, 2016-2027 (USD Million)

TABLE 13    Others market size, by region, 2016-2027 (USD Million)

TABLE 14    Drug treatment market size, by region, 2016-2027 (USD Million)

TABLE 15    Topical therapy market size, by region, 2016-2027 (USD Million)

TABLE 16    Allylamine market size, by region, 2016-2027 (USD Million)

TABLE 17    Azole market size, by region, 2016-2027 (USD Million)

TABLE 18    Griseofulvin market size, by region, 2016-2027 (USD Million)

TABLE 19    Others market size, by region, 2016-2027 (USD Million)

TABLE 20    Hospital pharmacies market size, by region, 2016-2027 (USD Million)

TABLE 21    Retail pharmacies market size, by region, 2016-2027 (USD Million)

TABLE 22    Online pharmacies market size, by region, 2016-2027 (USD Million)

TABLE 23    North America onychomycosis treatment market size, by country, 2016-2027 (USD Million)

TABLE 24    North America onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 25    North America onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 26    North America onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 27    North America onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 28    U.S. onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 29    U.S. onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 30    U.S. onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 31    U.S. onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 32    Canada onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 33    Canada onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 34    Canada onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 35    Canada onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 36    Europe onychomycosis treatment market size, by country, 2016-2027 (USD Million)

TABLE 37    Europe onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 38    Europe onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 39    Europe onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 40    Europe onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 41    Germany onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 42    Germany onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 43    Germany onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 44    Germany onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 45    France onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 46    France onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 47    France onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 48    France onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 49    UK onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 50    UK onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 51    UK onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 52    UK onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 53    Italy onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 54    Italy onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 55    Italy onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 56    Italy onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 57    Spain onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 58    Spain onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 59    Spain onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 60    Spain onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 61    Asia Pacific onychomycosis treatment market size, by country, 2016-2027 (USD Million)

TABLE 62    Asia Pacific onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 63    Asia Pacific onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 64    Asia Pacific onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 65    Asia Pacific onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 66    China onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 67    China onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 68    China onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 69    China onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 70    Japan onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 71    Japan onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 72    Japan onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 73    Japan onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 74    India onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 75    India onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 76    India onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 77    India onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 78    South Korea onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 79    South Korea onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 80    South Korea onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 81    South Korea onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 82    Australia onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 83    Australia onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 84    Australia onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 85    Australia onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 86    Latin America onychomycosis treatment market size, by country, 2016-2027 (USD Million)

TABLE 87    Latin America onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 88    Latin America onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 89    Latin America onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 90    Latin America onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 91    Brazil onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 92    Brazil onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 93    Brazil onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 94    Brazil onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 95    Mexico onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 96    Mexico onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 97    Mexico onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 98    Mexico onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 99    Argentina onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 100    Argentina onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 101    Argentina onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 102    Argentina onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 103    MEA onychomycosis treatment market size, by country, 2016-2027 (USD Million)

TABLE 104    MEA onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 105    MEA onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 106    MEA onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 107    MEA onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 108    Saudi Arabia onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 109    Saudi Arabia onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 110    Saudi Arabia onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 111    Saudi Arabia onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 112    UAE onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 113    UAE onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 114    UAE onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 115    UAE onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

TABLE 116    South Africa onychomycosis treatment market size, by type, 2016-2027 (USD Million)

TABLE 117    South Africa onychomycosis treatment market size, by treatment type, 2016-2027 (USD Million)

TABLE 118    South Africa onychomycosis treatment market size, by drug class, 2016-2027 (USD Million)

TABLE 119    South Africa onychomycosis treatment market size, by distribution channel, 2016-2027 (USD Million)

Charts & Figures

FIG. 1    Industry segmentation

FIG. 2    Global onychomycosis treatment market size, 2016 - 2027 (USD Million)

FIG. 3    Growth potential analysis, by type

FIG. 4    Growth potential analysis, by treatment type

FIG. 5    Growth potential analysis, by drug class

FIG. 6    Growth potential analysis, by distribution channel

FIG. 7    Porter’s analysis

FIG. 8    Competitive matrix analysis, 2020

FIG. 9    PESTEL analysis

FIG. 10    Key segment trends, by type

FIG. 11    Key segment trends, by treatment type

FIG. 12    Key segment trends, by drug class

FIG. 13    Key segment trends, by distribution channel

FIG. 14    Key regional trends, by region

FIG. 15    Strategy dashboard, 2020